TIBER CREEK GROUP for JAZZ PHARMACEUTICALS
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues related to the FDA STATES Act (S. 3032), and Health and Human Services pertaining to CBD policies.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MICHAEL GONZALEZ | — |
| EMILY KIRLIN | — |
| MATTHEW LEFFINGWELL | — |
| TIMOTHY A MOLINO | — |
Budget/Appropriations BUD
Appropriations issues related to the FDA CBD products, HHS pertaining to CBD policy. Fiscal Year 2021 Labor/HHS Education funding bill
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MICHAEL GONZALEZ | — |
| EMILY KIRLIN | — |
| MATTHEW LEFFINGWELL | — |
| TIMOTHY A MOLINO | — |
Medical/Disease Research/Clinical Labs MED
Issues related to the FDA and the STATES Act (S. 3032), HHS pertaining to CBD policy.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MICHAEL GONZALEZ | — |
| EMILY KIRLIN | — |
| MATTHEW LEFFINGWELL | — |
| TIMOTHY A MOLINO | — |
Support LegiList
This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.